Postpartum weight loss. Honestly.

What actually changes postpartum

Pregnancy is a year-long transformation. Delivery is a sudden event. The body does not reset overnight. Hormones that were sustaining pregnancy drop rapidly. Milk production starts. Sleep is broken. Cortisol climbs. Pelvic floor and abdominal muscles are recovering. And somewhere in the middle of all that, many new mothers are told to get back in shape.

Postpartum weight retention is real. Roughly 1 in 5 women in the US retain 10 or more pounds one year after delivery. The reasons are complex: hormonal shifts, sleep deprivation, reduced activity, eating convenience, breastfeeding patterns that differ from expectations, mental health challenges, and the practical impossibility of following any plan when you are managing a newborn.

GLP-1 and breastfeeding: the honest answer

GLP-1 medications are not recommended during pregnancy or breastfeeding. FDA prescribing information for brand-name GLP-1 products including Wegovy, Ozempic, Zepbound, and Mounjaro advises against use in women who are pregnant or nursing. Data on how these medications transfer into breast milk and affect infants is limited.

This is the firm answer. It matters more than any ranking opinion or social media post. If you are actively breastfeeding, you should not be taking GLP-1 medications. This is not a matter of risk tolerance. It is a matter of lacking safety data in an infant population, which is a high bar for any medication.

A Puri-affiliated provider will screen for pregnancy and breastfeeding during intake and will not prescribe GLP-1 to a breastfeeding mother. This is the correct answer.

When GLP-1 may become an option

After you have weaned from breastfeeding and are not pregnant or planning pregnancy, GLP-1 may be an option to discuss with a provider. Many women wean at 6 to 12 months, some earlier, some later. There is no one right answer about timing.

The other important consideration is future pregnancy. GLP-1 medications should be discontinued well before a planned pregnancy. Current guidance from manufacturers and clinicians is generally to stop GLP-1 at least 2 months before trying to conceive to allow the medication to clear the system. If you plan to have more children in the near term, factor this into your timeline.

A realistic early-postpartum plan

In the first year after delivery, especially while breastfeeding, the foundation of weight management is not medication. It is recovery, nutrition, sleep when possible, gentle movement, and mental health support. Not in that order. All at once.

Nutrition that supports recovery

Postpartum bodies need protein, iron, iodine, choline, DHA, and calories. Crash dieting while breastfeeding is a bad idea for milk supply and energy. A whole foods approach with adequate protein at every meal is more useful than any specific restriction. Talk to a registered dietitian if you have access to one. Many insurance plans cover postpartum nutrition counseling.

Movement appropriate for your recovery

Most providers clear low-impact movement around 6 weeks postpartum and more intense activity by 12 weeks, assuming no complications. Walking, gentle strength work, pelvic floor rehabilitation, and posture work are all valuable. Running and high-impact exercise often need more time, especially after cesarean delivery or significant tearing.

Sleep, as much as possible

Sleep deprivation worsens insulin resistance, raises cortisol, and makes weight loss harder. There is no clever workaround. Sleep when the baby sleeps is not always possible, but protecting any sleep you can get matters more than any supplement.

Mental health support

Postpartum depression and anxiety affect a significant percentage of new mothers and are often underdiagnosed. These conditions can drive weight retention through stress, appetite changes, and sleep disruption. Talk to your OB/GYN, primary care provider, or a perinatal mental health specialist if you are struggling. This is not weakness. It is a condition with effective treatments.

What the research has examined

Most large GLP-1 weight loss trials excluded pregnant and breastfeeding women by design. As a result, direct clinical trial data on GLP-1 use in the early postpartum period is limited. What we know comes from the broader trials of brand-name products and observational data:

• STEP and SURMOUNT. Brand-name semaglutide and tirzepatide reported substantial average body weight reductions in non-pregnant, non-breastfeeding adults with obesity or overweight plus a weight-related condition.
• Lack of lactation data. Limited data on transfer into breast milk is one of the reasons these medications are contraindicated during breastfeeding. Until more is known, the conservative recommendation is to avoid use in nursing mothers.
• Preconception planning. Some research suggests that losing weight before pregnancy can improve outcomes in the next pregnancy. Whether GLP-1 specifically improves preconception outcomes in this way has not been definitively established.

Who should NOT consider GLP-1

• Any mother who is currently breastfeeding.
• Any mother who is currently pregnant.
• Any woman actively trying to conceive or planning pregnancy in the near term.
• A personal or family history of medullary thyroid carcinoma or MEN2.
• Personal history of pancreatitis.
• Active or recent cancer.
• Severe gastroparesis.
• Active eating disorder (particularly concerning in the postpartum period).
• Certain medication interactions.

How to think about the decision

• Recovery first. Your body went through a year of transformation. Give it time.
• Foundation work always. Nutrition, sleep, gentle movement, and mental health support matter with or without medication.
• GLP-1 is not for breastfeeding mothers. Wait until you are weaned and not planning near-term pregnancy.
• Be honest about timing. If more children are in your plan, factor that into decisions.
• Find a provider who respects your whole picture. Postpartum women deserve real conversations, not rushed answers.

When you are ready and not breastfeeding, start your assessment.